Juno Therapeutics, Inc. 4
4 · Juno Therapeutics, Inc. · Filed Feb 9, 2017
Insider Transaction Report
Form 4
Levitsky Hyam
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-02-07+68,182→ 68,182 totalExercise: $20.76Exp: 2027-02-06→ Common Stock (68,182 underlying) - Award
Common Stock
2017-02-07+14,634→ 131,334 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the 2014 Equity Incentive Plan. 25% of the RSUs vest on each anniversary of February 7, 2017.
- [F2]1/48th of the shares subject to the option vests and becomes exercisable on March 7, 2017 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter.